Cathepsin D Increase in Monkey Brain Linked to Parkinson's Disease
Author Information
Author(s): Yelamanchili Sowmya V, Chaudhuri Amrita Datta, Flynn Claudia T, Fox Howard S
Primary Institution: University of Nebraska Medical Center
Hypothesis
Cat D can act as a molecular trigger for neuronal damage in the caudate nucleus.
Conclusion
The study found that increased levels of Cathepsin D in the caudate nucleus are associated with neuronal damage in a model of Parkinson's disease.
Supporting Evidence
- Chronic MPTP treatment led to significant upregulation of Cat D in the caudate nucleus.
- Increased Cat D levels correlated with neuronal death and apoptosis.
- The study identified a four-fold increase in lysosomes in neurons of MPTP-treated monkeys.
Takeaway
When monkeys were treated to mimic Parkinson's disease, a protein called Cathepsin D increased in their brains, which might hurt their brain cells.
Methodology
The study used chronic MPTP treatment in rhesus monkeys to model Parkinson's disease and assessed Cat D levels through immunofluorescence and PCR.
Limitations
The study primarily focused on a nonhuman primate model, which may not fully replicate human Parkinson's disease.
Participant Demographics
Adult male rhesus monkeys, aged 6-8 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website